Macrogenics Q3 EPS $(0.91) Beats $(0.98) Estimate, Sales $18.741M Miss $19.12M Estimate

Macrogenics (NASDAQ:MGNX) reported quarterly losses of $(0.91) per share which beat the analyst consensus estimate of $(0.98) by 7.14 percent. This is a 12.35 percent decrease over losses of $(0.81) per share from the

Benzinga · 11/06/2019 21:27

Macrogenics (NASDAQ:MGNX) reported quarterly losses of $(0.91) per share which beat the analyst consensus estimate of $(0.98) by 7.14 percent. This is a 12.35 percent decrease over losses of $(0.81) per share from the same period last year. The company reported quarterly sales of $18.741 million which missed the analyst consensus estimate of $19.12 million by 1.98 percent. This is a 9.89 percent decrease over sales of $20.798 million the same period last year.